{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:40:37Z","timestamp":1790458837055,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/jid.2014.296","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T13:48:15Z","timestamp":1405950495000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative Effectiveness of Topical Drugs in Dermatologic Priority Diseases: Geometry of Randomized Trial Networks"],"prefix":"10.1016","volume":"135","author":[{"given":"Annabel","family":"Maruani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Lorette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"le Cleach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.296_bb0010","doi-asserted-by":"crossref","first-page":"e28820","DOI":"10.1371\/journal.pone.0028820","article-title":"Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov","volume":"7","author":"Bourgeois","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1038\/jid.2014.296_bb0015","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/jama.2012.471","article-title":"A push for comparative effectiveness: US initiatives aim to empower patients, physicians. Interview by Bridget M. Kuehn","volume":"307","author":"Clancy","year":"2012","journal-title":"JAMA"},{"key":"10.1038\/jid.2014.296_bb0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/clpt.2011.279","article-title":"The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics","volume":"91","author":"Dunn","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/jid.2014.296_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archinternmed.2011.1209","article-title":"Lack of head-to-head trials and fair control arms","volume":"172","author":"Estellat","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1038\/jid.2014.296_bb0030","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2009.47","article-title":"Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study","volume":"129","author":"Ghodsi","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.296_bb0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2010.240","article-title":"Characteristics of published comparative effectiveness studies of medications","volume":"303","author":"Hochman","year":"2010","journal-title":"JAMA"},{"key":"10.1038\/jid.2014.296_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40268-013-0004-x","article-title":"Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients","volume":"3","author":"Hon","year":"2013","journal-title":"Drugs R D"},{"key":"10.1038\/jid.2014.296_bb0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2307\/1934145","article-title":"The nonconcept of species diversity: a critique and alternative parameters","volume":"52","author":"Hurlbert","year":"1971","journal-title":"Ecology"},{"key":"10.1038\/jid.2014.296_bb0050","series-title":"Initial National Priorities for Comparative Effectiveness Research","author":"IOM (Institute of Medicine)","year":"2009"},{"key":"10.1038\/jid.2014.296_bb0055","doi-asserted-by":"crossref","first-page":"c4875","DOI":"10.1136\/bmj.c4875","article-title":"The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence","volume":"341","author":"Ioannidis","year":"2010","journal-title":"BMJ"},{"key":"10.1038\/jid.2014.296_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrrheum.2013.134","article-title":"Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales","volume":"9","author":"Ioannidis","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1038\/jid.2014.296_bb0065","doi-asserted-by":"crossref","first-page":"e6512","DOI":"10.1136\/bmj.e6512","article-title":"Neglected tropical diseases: survey and geometry of randomised evidence","volume":"345","author":"Kappagoda","year":"2012","journal-title":"BMJ"},{"key":"10.1038\/jid.2014.296_bb0070","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaad.2006.07.005","article-title":"Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study","volume":"55","author":"Katz","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.296_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jclinepi.2013.10.015","article-title":"Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma","volume":"67","author":"Kim","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/jid.2014.296_bb0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14728214.2013.861418","article-title":"Emerging topical treatments for psoriasis","volume":"18","author":"Kivelevitch","year":"2013","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1038\/jid.2014.296_bb0085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1524-4725.2011.02122.x","article-title":"Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications","volume":"37","author":"Lapolla","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1038\/jid.2014.296_bb0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd2996","article-title":"Psoriasis market","volume":"8","author":"Melnikova","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/jid.2014.296_bb0095","doi-asserted-by":"crossref","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills","year":"2013","journal-title":"BMJ"},{"key":"10.1038\/jid.2014.296_bb0100","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1038\/jid.2012.497","article-title":"Comparative effectiveness research","volume":"133","author":"Nambudiri","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.296_bb0105","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jclinepi.2010.11.017","article-title":"Homophily and co-occurrence patterns shape randomized trials agenda: illustration in antifungal agents","volume":"64","author":"Rizos","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/jid.2014.296_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1038\/jid.2014.296_bb0115","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-148-7-200804010-00011","article-title":"Exploring the geometry of treatment networks","volume":"148","author":"Salanti","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1038\/jid.2014.296_bb0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.annder.2012.06.039","article-title":"Enqu\u00eate sur la prise en charge des patients acn\u00e9iques en France","volume":"139","author":"Seit\u00e9","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1038\/jid.2014.296_bb0125","first-page":"1221","article-title":"Vehicle or placebo? Investigators use incorrect terminology in randomized controlled trials half of the time: a systematic review of randomized controlled trials published in three major dermatology journals","volume":"9","author":"Shamsudin","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1038\/jid.2014.296_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-151-3-200908040-00125","article-title":"Comparative effectiveness research: a report from the Institute of Medicine","volume":"151","author":"Sox","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1038\/jid.2014.296_bb0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/eci.12074","article-title":"Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review","volume":"43","author":"Stamatakis","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/jid.2014.296_bb0140","first-page":"74","article-title":"The checkerboard score and species distributions","volume":"85","author":"Stone","year":"1990","journal-title":"Ecologia"},{"key":"10.1038\/jid.2014.296_bb0145","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1111\/1755-5922.12050","article-title":"Geometry of the randomized evidence for treatments of pulmonary hypertension","volume":"31","author":"Tonelli","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1038\/jid.2014.296_bb0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archdermatol.2011.1399","article-title":"Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis","volume":"148","author":"Wan","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2014.296_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"10.1038\/jid.2014.296_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1473-2130.2004.00059.x","article-title":"Alpha-hydroxyacids and carboxylic acids","volume":"3","author":"Yu","year":"2004","journal-title":"J Cosmet Dermatol"},{"key":"10.1038\/jid.2014.296_bb0165","series-title":"Chronic venous ulcers: a comparative effectiveness review of treatment modalities","author":"Zenilman","year":"2013"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15370536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15370536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:46:44Z","timestamp":1743976004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15370536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0022202X15370536"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.296","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness of Topical Drugs in Dermatologic Priority Diseases: Geometry of Randomized Trial Networks","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}